Cholangiocarcinoma Clinical Trials in München
4 recruitingMünchen, Germany
Showing 1–4 of 4 trials
Recruiting
Phase 2
Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma
CholangiocarcinomaIDH Mutation
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest40 enrolled7 locationsNCT07260175
Recruiting
Phase 3
An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma
Cholangiocarcinoma
Servier Affaires Médicales220 enrolled84 locationsNCT05876754
Recruiting
Phase 4
Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy
Hilar Cholangiocarcinoma
University of Leipzig258 enrolled20 locationsNCT05551299
Recruiting
Phase 3
Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma
Cholangiocarcinoma
TransThera Sciences (Nanjing), Inc.200 enrolled87 locationsNCT05948475